Bacteremia SepsisNCT03577366
Prevalence and Characterization of Diagnostic Error Among Patients With Bacteremia
An observational study of Bacteremia Sepsis, run by Aimee Li.
Trial summary
Diagnostic error is an important but often under-recognized source of adverse events in the hospital. This study is focused on the delayed or missed diagnosis of sepsis associated with bacteremia among patients admitted to The Ottawa Hospital. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Bacteremia Sepsis
- How many people
- 1,570 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2016to 13 Aug 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: Patients included in this study will be >18 years old with a positive blood culture taken in the Emergency Department or on admission to the hospital between January 2016-August 13th,2017. No data entered into the medical chart before or after the specified dates will be collected. Among these patients, we will only review charts for those patients who did not receive treatment for sepsis on presentation by an Emergency Room physician or consultant.
Who may be able to join
- >18 years old with a positive blood culture taken in the Emergency Department or on admission to the hospital between January 2016-August 13th,2017. No data entered into the medical chart before or after the specified dates will be collected.
Who cannot join
None listed.
About this study
Diagnostic error is an important but often under-recognized source of adverse events in the hospital. This study is focused on the delayed or missed diagnosis of sepsis associated with bacteremia among patients admitted to The Ottawa Hospital. The aim of this study is to determine the prevalence and characterization of diagnostic error among patients admitted to the at The Ottawa Hospital with sepsis associated with a positive blood culture. This study will consist of a retrospective chart review of all patients who are greater than 18 years with positive blood culture taken within 12 hours of presenting to the Emergency Department of Ottawa Hospital Civic and General Campus between January 2016 to August 13th 2017. For charts that are eligible for review for diagnostic errors, the qSOFA (Quick Sequential [Sepsis-related] Organ Failure Assessment) score at time at admission will be used to identify those patients who were at risk of serious harm because of a missed diagnosis of sepsis and lack of treatment. Patient variables will be collected and compared between the following three groups: (1) patients who received antibiotics within 24 hours, (2) patients who did not receive antibiotics within 24 hours and who did not meet qSOFA criteria, and (3) patients who did not receive antibiotic within 24 hours and who met qSOFA criteria. Variables to be studied include age, gender, hospital campus, admitting service, day of admission (weekend vs. weekday), time of admission (night vs. day), length of stay, disposition and Elixhauser Comorbidity Index. For charts eligible for review for diagnostic error, the DEER (Diagnostic Error Evaluation Research) Taxonomy tool will be used to classify cases per the location and type of error that occurred in the diagnostic process.
Read the detailed description
Background and Rationale:
Diagnostic error is an important but often under-recognized source of adverse events in the hospital. It ranks second as the cause of adverse events1. Studies have indicated that major diagnostic discrepancies are found in 10-20% of autopsies, and that diagnostic error is the leading cause of malpractice litigation for physicians in Canada2. Furthermore, diagnostic error is of upmost importance in the eyes of our patients: Studies have cited that 55% of patients indicated diagnostic error as their chief concern when seeing a physician. Diagnostic error occurs most commonly in areas where there is a high degree of diagnostic uncertainty such as General Internal Medicine.
Diagnostic error can be classified as either systems or cognitive errors. Systems errors involve technical failure, equipment problems and organization flaws. Systems errors have been the focus of most quality improvement and patient safety research in the past few decades. In contrast, cognitive sources of errors have received little attention despite studies indicating that the cognitive factors play in a role in up to 74% of cases involving diagnostic error. Cognitive error is defined by faulty knowledge, data gathering and synthesis of information. They often occur as the result of biases and heuristics used by physicians during the diagnostic process.
Most diagnostic errors are associated with common conditions such as sepsis, pulmonary embolism, drug intoxication, myocardial infarction and appendicitis.
This study is focused on the delayed or missed diagnosis of sepsis associated with bacteremia among patients admitted to The Ottawa Hospital. Sepsis is a common and important diagnosis. Delayed treatment is associated with significant morbidity and mortality9. Therefore, timely and correct diagnosis of sepsis is of upmost importance. No research thus far has been conducted assess the incidence and etiology of diagnostic error among patients with sepsis.
Sepsis is defined as life-threatening organ dysfunction caused by dysregulated host response to infection and the definitive diagnosis of sepsis is often complex. Given this, this study will include only patients with a missed diagnosis of sepsis who also have a positive blood cultures given the need for an objective marker of the diagnosis.
Aims and Objectives:
The aim of this study is to determine the prevalence and characterization of diagnostic error among patients admitted to the at The Ottawa Hospital with sepsis associated with a positive blood culture.
Study Design and Methods:
This study will consist of a retrospective chart review of all patients who are greater than 18 years with positive blood culture taken within 12 hours of presenting to the Emergency Department of Ottawa Hospital Civic and General Campus between January 2016 to August 13th 2017.
For patients with a positive blood culture, charts will be reviewed only for those patients who did not receive treatment for sepsis on presentation by an Emergency Room (ER) physician or consultant within the first 24 hours.
Patients with positive blood cultures with an organism that is deemed a probable-contaminant organism from the study will be excluded. For this study, probable contaminant organisms will be defined as the following: (1) Coagulase-negative staphylococci (CoNs), (2) Bacillus species other than Bacillus anthracis, (3) Propionbacterium acnes and (4) Corynebacterium species. Coagulase negative staphylocci (CoNs) will be considered as a probable-contaminant if detected in only one bottle or the minority of bottles within a blood culture set in the absence of risk factors for invasive infection. Risk factors for CoNs invasive infection include intravascular catheters, hemodialysis catheters, vascular grafts, recent prosthetic joints or hardware, presence of pacemaker or prosthetic cardiac valves. Bacillus species, Proprionbacterium acnes and Corynebacterium species, will be considered contaminants if they are detected in one or the minority of bottles in a blood culture set.
For charts that are eligible for review for diagnostic errors, the qSOFA (Quick Sequential [Sepsis-related] Organ Failure Assessment) score at time at admission will be used to identify those patients who were at risk of serious harm because of a missed diagnosis of sepsis and lack of treatment. The qSOFA is a score included in the Sepsis-3 Recommendations published in 2016, and is a validated bedside tool used for out-of-hospital, emergency department or general hospital ward settings in which patients with a suspected infection can be rapidly identified as being more likely to have poor outcomes typical of sepsis. The score consists of the following criteria and a score of 2 or more criteria correlates to worse outcomes: (1) respiratory rate of 22/min or greater, (2) altered mentation and (3) systolic blood pressure of 100mm Hg or less.
Patient variables will be collected and compared between the following three groups: (1) patients who received antibiotics within 24 hours, (2) patients who did not receive antibiotics within 24 hours and who did not meet qSOFA criteria, and (3) patients who did not receive antibiotic within 24 hours and who met qSOFA criteria. Variables to be studied include age, gender, hospital campus, admitting service, day of admission (weekend vs. weekday), bacteria species, time of admission (night vs. day), length of stay, disposition and Elixhauser Comorbidity Index.
For charts eligible for review for diagnostic error, the DEER (Diagnostic Error Evaluation Research) Taxonomy tool will be used to classify cases per the location and type of error that occurred in the diagnostic process.
- Conditions
- Bacteremia Sepsis
- Keywords
- Bacteremia, Sepsis, Diagnostic Error
- Medical subject headings
- Bacteremia, Sepsis
What is being measured
The primary outcome is the main question the study is designed to answer.
Diagnostic Error
Prevalence and Characterization of Diagnostic Error
Measured: January 2016-August 13th, 2017
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jul 2018
- Study start1 Jan 2016
- Primary completion13 Aug 2017
- Study completion13 Aug 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Bacteremia SepsisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 1,570 participants (actual)
Sponsor and investigators
- Lead sponsor
- Aimee Li
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Aimee Li, University of Ottawa
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03577366
- Sponsor's protocol ID
- 7099
- Status last verified
- Jul 2018
- First submitted
- 24 Jun 2018
- Last updated
- 6 Jul 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Jul 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence and Characterization of Diagnostic Error Among Patients With Bacteremia
- ClinicalTrials.gov ID
- NCT03577366
- Acronym / sponsor ID
- 7099
- Conditions
- Bacteremia Sepsis
- Keywords
- Bacteremia, Sepsis, Diagnostic Error
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,570 participants (actual)
- Lead sponsor
- Aimee LiUniversity, hospital or other
- Study start
- 1 Jan 2016 (actual)
- Primary completion
- 13 Aug 2017 (actual)
- Study completion
- 13 Aug 2017 (actual)
- First posted
- 5 Jul 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Diagnostic error is an important but often under-recognized source of adverse events in the hospital. This study is focused on the delayed or missed diagnosis of sepsis associated with bacteremia among patients admitted to The Ottawa Hospital. The aim of this study is to determine the prevalence and characterization of diagnostic error among patients admitted to the at The Ottawa Hospital with sepsis associated with a positive blood culture. This study will consist of a retrospective chart review of all patients who are greater than 18 years with positive blood culture taken within 12 hours of presenting to the Emergency Department of Ottawa Hospital Civic and General Campus between January 2016 to August 13th 2017. For charts that are eligible for review for diagnostic errors, the qSOFA (Quick Sequential [Sepsis-related] Organ Failure Assessment) score at time at admission will be used to identify those patients who were at risk of serious harm because of a missed diagnosis of sepsis and lack of treatment. Patient variables will be collected and compared between the following three groups: (1) patients who received antibiotics within 24 hours, (2) patients who did not receive antibiotics within 24 hours and who did not meet qSOFA criteria, and (3) patients who did not receive antibiotic within 24 hours and who met qSOFA criteria. Variables to be studied include age, gender, hospital campus, admitting service, day of admission (weekend vs. weekday), time of admission (night vs. day), length of stay, disposition and Elixhauser Comorbidity Index. For charts eligible for review for diagnostic error, the DEER (Diagnostic Error Evaluation Research) Taxonomy tool will be used to classify cases per the location and type of error that occurred in the diagnostic process.
Detailed description
Background and Rationale:
Diagnostic error is an important but often under-recognized source of adverse events in the hospital. It ranks second as the cause of adverse events1. Studies have indicated that major diagnostic discrepancies are found in 10-20% of autopsies, and that diagnostic error is the leading cause of malpractice litigation for physicians in Canada2. Furthermore, diagnostic error is of upmost importance in the eyes of our patients: Studies have cited that 55% of patients indicated diagnostic error as their chief concern when seeing a physician. Diagnostic error occurs most commonly in areas where there is a high degree of diagnostic uncertainty such as General Internal Medicine.
Diagnostic error can be classified as either systems or cognitive errors. Systems errors involve technical failure, equipment problems and organization flaws. Systems errors have been the focus of most quality improvement and patient safety research in the past few decades. In contrast, cognitive sources of errors have received little attention despite studies indicating that the cognitive factors play in a role in up to 74% of cases involving diagnostic error. Cognitive error is defined by faulty knowledge, data gathering and synthesis of information. They often occur as the result of biases and heuristics used by physicians during the diagnostic process.
Most diagnostic errors are associated with common conditions such as sepsis, pulmonary embolism, drug intoxication, myocardial infarction and appendicitis.
This study is focused on the delayed or missed diagnosis of sepsis associated with bacteremia among patients admitted to The Ottawa Hospital. Sepsis is a common and important diagnosis. Delayed treatment is associated with significant morbidity and mortality9. Therefore, timely and correct diagnosis of sepsis is of upmost importance. No research thus far has been conducted assess the incidence and etiology of diagnostic error among patients with sepsis.
Sepsis is defined as life-threatening organ dysfunction caused by dysregulated host response to infection and the definitive diagnosis of sepsis is often complex. Given this, this study will include only patients with a missed diagnosis of sepsis who also have a positive blood cultures given the need for an objective marker of the diagnosis.
Aims and Objectives:
The aim of this study is to determine the prevalence and characterization of diagnostic error among patients admitted to the at The Ottawa Hospital with sepsis associated with a positive blood culture.
Study Design and Methods:
This study will consist of a retrospective chart review of all patients who are greater than 18 years with positive blood culture taken within 12 hours of presenting to the Emergency Department of Ottawa Hospital Civic and General Campus between January 2016 to August 13th 2017.
For patients with a positive blood culture, charts will be reviewed only for those patients who did not receive treatment for sepsis on presentation by an Emergency Room (ER) physician or consultant within the first 24 hours.
Patients with positive blood cultures with an organism that is deemed a probable-contaminant organism from the study will be excluded. For this study, probable contaminant organisms will be defined as the following: (1) Coagulase-negative staphylococci (CoNs), (2) Bacillus species other than Bacillus anthracis, (3) Propionbacterium acnes and (4) Corynebacterium species. Coagulase negative staphylocci (CoNs) will be considered as a probable-contaminant if detected in only one bottle or the minority of bottles within a blood culture set in the absence of risk factors for invasive infection. Risk factors for CoNs invasive infection include intravascular catheters, hemodialysis catheters, vascular grafts, recent prosthetic joints or hardware, presence of pacemaker or prosthetic cardiac valves. Bacillus species, Proprionbacterium acnes and Corynebacterium species, will be considered contaminants if they are detected in one or the minority of bottles in a blood culture set.
For charts that are eligible for review for diagnostic errors, the qSOFA (Quick Sequential [Sepsis-related] Organ Failure Assessment) score at time at admission will be used to identify those patients who were at risk of serious harm because of a missed diagnosis of sepsis and lack of treatment. The qSOFA is a score included in the Sepsis-3 Recommendations published in 2016, and is a validated bedside tool used for out-of-hospital, emergency department or general hospital ward settings in which patients with a suspected infection can be rapidly identified as being more likely to have poor outcomes typical of sepsis. The score consists of the following criteria and a score of 2 or more criteria correlates to worse outcomes: (1) respiratory rate of 22/min or greater, (2) altered mentation and (3) systolic blood pressure of 100mm Hg or less.
Patient variables will be collected and compared between the following three groups: (1) patients who received antibiotics within 24 hours, (2) patients who did not receive antibiotics within 24 hours and who did not meet qSOFA criteria, and (3) patients who did not receive antibiotic within 24 hours and who met qSOFA criteria. Variables to be studied include age, gender, hospital campus, admitting service, day of admission (weekend vs. weekday), bacteria species, time of admission (night vs. day), length of stay, disposition and Elixhauser Comorbidity Index.
For charts eligible for review for diagnostic error, the DEER (Diagnostic Error Evaluation Research) Taxonomy tool will be used to classify cases per the location and type of error that occurred in the diagnostic process.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Patients included in this study will be >18 years old with a positive blood culture taken in the Emergency Department or on admission to the hospital between January 2016-August 13th,2017. No data entered into the medical chart before or after the specified dates will be collected. Among these patients, we will only review charts for those patients who did not receive treatment for sepsis on presentation by an Emergency Room physician or consultant.
Key inclusion criteria (1 listed)
- >18 years old with a positive blood culture taken in the Emergency Department or on admission to the hospital between January 2016-August 13th,2017. No data entered into the medical chart before or after the specified dates will be collected.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Diagnostic Error
Time frame: January 2016-August 13th, 2017
Prevalence and Characterization of Diagnostic Error
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Jul 2018.
Related trials for Bacteremia Sepsis
Not yet recruitingPhase 4
Oral Switch in Bloodstream Infections in Immunocompromised Children
Bloodstream Infection, Bloodstream Infection Due to Central Venous Catheter
Not yet recruiting
Evaluation of an AI-Assisted Tool for CLABSI Surveillance at VA Medical Centers
Central Line-Associated Bloodstream Infection (CLABSI), Bacteremia
RecruitingPhase 2
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia
RecruitingObservational study
Middle East Study of Infections in Patients With Hematological Malignancies
Hematological Malignancy, Hematopoetic Stem Cell Transplantation
Not yet recruitingObservational study
Comparative Study of the Genomic Characteristics of Uropathogenic Escherichia Coli According to the Severity of Community-Acquired Urinary Tract Infections in Guadeloupe (COLIGENURI)
Urinary Tract Infections
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Bacteremia Sepsis, run by Aimee Li.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Diagnostic Error (time frame: January 2016-August 13th, 2017). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2018.